Form 4: Pfizer CEO Bourla Reports Stock Transactions

Pfizer Chairman and CEO Albert Bourla has reported transactions involving phantom stock units acquired under a company plan.

Summary

• Albert Bourla, Chairman & CEO of Pfizer Inc. (PFE), reported a transaction on April 30, 2026.
• The transaction involved the acquisition of 22 Phantom Stock Units (SSP).
• These units are part of the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan.
• Each unit represents one phantom share of common stock.
• The units are settled in cash upon separation from service and can be transferred to an alternative investment account.
• Following this transaction, Bourla beneficially owns 760,229 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports a routine insider transaction related to executive compensation rather than a significant strategic or financial event.

Positives

• The CEO's continued participation and reporting under company plans indicate ongoing engagement.
• The acquisition of phantom stock units suggests a long-term incentive structure aligned with company performance.

Negatives

• The filing does not contain information that would be considered negative in terms of financial performance or company operations.

Risks

• The value of phantom stock units is tied to the company's stock price, thus subject to market volatility.
• The settlement of these units upon separation from service means their ultimate value realization is contingent on future events.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports on a specific transaction by an insider.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in publicly traded companies, providing transparency into executive ownership and trading activity. This filing by Pfizer's CEO is typical for reporting the acquisition of equity-linked compensation.

Stakeholder Impact

• Shareholders: Increased transparency into executive compensation and ownership structure.
• Employees: Reinforces the company's executive compensation plans and incentive structures.

Next Steps

• The phantom stock units will be settled in cash following the reporting person's separation from service.
• The reporting person may transfer the units into an alternative investment account at any time.

Key Dates

Keywords

Pfizer, PFE, Albert Bourla, Form 4, SEC Filing, Insider Trading, Stock Options, Phantom Stock, Deferred Compensation, Executive Compensation